[go: up one dir, main page]

AU2001268197A1 - Human pancreatic islet glucose-6-phosphatase - Google Patents

Human pancreatic islet glucose-6-phosphatase

Info

Publication number
AU2001268197A1
AU2001268197A1 AU2001268197A AU6819701A AU2001268197A1 AU 2001268197 A1 AU2001268197 A1 AU 2001268197A1 AU 2001268197 A AU2001268197 A AU 2001268197A AU 6819701 A AU6819701 A AU 6819701A AU 2001268197 A1 AU2001268197 A1 AU 2001268197A1
Authority
AU
Australia
Prior art keywords
phosphatase
pancreatic islet
human pancreatic
islet glucose
glucose
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001268197A
Inventor
Hong Chen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Millennium Pharmaceuticals Inc
Original Assignee
Millennium Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Millennium Pharmaceuticals Inc filed Critical Millennium Pharmaceuticals Inc
Publication of AU2001268197A1 publication Critical patent/AU2001268197A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU2001268197A 2000-06-02 2001-06-04 Human pancreatic islet glucose-6-phosphatase Abandoned AU2001268197A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/586,511 US6627425B1 (en) 2000-06-02 2000-06-02 Human glucose-6-phosphatase molecules and uses thereof
US09/586,511 2000-06-02
PCT/US2001/018241 WO2001092497A2 (en) 2000-06-02 2001-06-04 Human pancreatic islet glucose-6-phosphatase

Publications (1)

Publication Number Publication Date
AU2001268197A1 true AU2001268197A1 (en) 2001-12-11

Family

ID=24346035

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001268197A Abandoned AU2001268197A1 (en) 2000-06-02 2001-06-04 Human pancreatic islet glucose-6-phosphatase

Country Status (4)

Country Link
US (3) US6627425B1 (en)
EP (1) EP1287122A2 (en)
AU (1) AU2001268197A1 (en)
WO (1) WO2001092497A2 (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6627425B1 (en) * 2000-06-02 2003-09-30 Millennium Pharmaceuticals, Inc. Human glucose-6-phosphatase molecules and uses thereof
US7048914B2 (en) * 2002-12-12 2006-05-23 Zoltan Laboratories Placental alkaline phosphatase to control diabetes
AU2003298036A1 (en) * 2002-12-12 2004-07-09 Zoltan Laboratories Placental alkaline phosphatase to control diabetes
EP2239329A1 (en) * 2003-03-07 2010-10-13 Alnylam Pharmaceuticals, Inc. Therapeutic compositions
EP1615611B1 (en) * 2003-04-09 2013-02-13 Alnylam Pharmaceuticals Inc. iRNA CONJUGATES
WO2005033267A2 (en) * 2003-05-20 2005-04-14 Albert Einstein College Of Medicine Of Yeshiva University Antigens targeted by prevalent pathogenic t cells in type 1 diabetes and uses thereof
US6905279B2 (en) * 2003-06-12 2005-06-14 The Coleman Company, Inc. Line connector
WO2005030032A2 (en) * 2003-09-22 2005-04-07 The Regents Of The University Of Colorado Use of islet glucose-6-phosphatase related protein as a diagnostic tool and therapeutic target for autoimmune diabetes
US20050261233A1 (en) * 2004-04-21 2005-11-24 Sanjay Bhanot Modulation of glucose-6-phosphatase translocase expression
US20090137485A1 (en) * 2005-03-17 2009-05-28 Dilorenzo Teresa P Antigens Targeted by Pathogenic T Cells in Type 1 Diabetes and Uses Thereof
US7695714B2 (en) * 2005-12-28 2010-04-13 Zoltan Laboratories Llc Use of alkaline phosphatase to maintain healthy tissue mass in mammals
US7981647B2 (en) 2008-03-03 2011-07-19 Joule Unlimited, Inc. Engineered CO2 fixing microorganisms producing carbon-based products of interest
US8048654B2 (en) * 2010-06-09 2011-11-01 Joule Unlimited Technologies, Inc. Methods and compositions for the recombinant biosynthesis of fatty acids and esters
JP2011528910A (en) * 2008-07-25 2011-12-01 アルニラム ファーマスーティカルズ インコーポレイテッド Enhanced siRNA silencing activity using common bases or mismatches in the sense strand
CN103725717A (en) 2008-10-17 2014-04-16 焦耳无限科技公司 Method of producing Microbiological ethyl alcohol
US20110020867A1 (en) * 2009-07-20 2011-01-27 Joule Unlimited, Inc. Constructs And Methods For Efficient Transformation Of Micro-Organisms For Production Of Carbon-Based Products Of Interest
US20140092529A1 (en) * 2011-02-28 2014-04-03 Nec Tokin Corporation Electroconductive polymer solution and method for producing the same, electroconductive polymer material, and solid electrolytic capacitor using the same and method for producing the same
US10415044B2 (en) 2014-12-23 2019-09-17 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Adeno-associated virus vectors encoding modified G6PC and uses thereof
ES2726914A1 (en) * 2018-04-09 2019-10-10 Univ Santiago Compostela Glucose-6-phosphatase 2 protein production method

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5654176A (en) * 1987-05-28 1997-08-05 Amrad Corporation Limited Fusion proteins containing glutathione-s-transferase
US6627425B1 (en) * 2000-06-02 2003-09-30 Millennium Pharmaceuticals, Inc. Human glucose-6-phosphatase molecules and uses thereof
WO2002010363A2 (en) 2000-07-28 2002-02-07 Incyte Genomics, Inc. Protein phosphatases

Also Published As

Publication number Publication date
WO2001092497A3 (en) 2002-08-29
WO2001092497A9 (en) 2002-12-12
US20020037555A1 (en) 2002-03-28
EP1287122A2 (en) 2003-03-05
WO2001092497A2 (en) 2001-12-06
US6623947B2 (en) 2003-09-23
US20050014241A1 (en) 2005-01-20
US6627425B1 (en) 2003-09-30

Similar Documents

Publication Publication Date Title
AU2001289098A1 (en) Implantable prosthesis
PL347924A1 (en) Stent
AU2002218743A1 (en) Intersomatic implant
AU2002237877A1 (en) Stent
AU2002359573A1 (en) Non-foreshortening stent
AU6364700A (en) Human synthetases
AU2001268197A1 (en) Human pancreatic islet glucose-6-phosphatase
AU2001263841A1 (en) Implant
AU2001233208A1 (en) Human sulfatases
AU138705S (en) Bracelet
AU2000254982A1 (en) Instrumented stent
AU141167S (en) Bracelet
AU2026101A (en) Stent
AU2002227925A1 (en) Human beta-defensin-3
AU2001270129A1 (en) Human phosphodiesterases
AU2001218611A1 (en) Stent
EP1329501A4 (en) Novel pla1
AUPR560201A0 (en) Stent
AU5838100A (en) Bio-regeneration bracelet
AU2002220638A1 (en) Joint prosthesis
GB2359181B (en) Educational aid
AU2001266932A1 (en) Human lyases
AU5190299A (en) Temporary prosthesis
GB2356551B (en) Locket
AU7372301A (en) Jewellery piece